NIBRT National Institute for Bioprocessing Research and Training

Just One Week to Go! Free Webinar: Generative AI Explained – Practical Starting Points for Biopharma Only one week left to join our upcoming webinar hosted by NIBRT, in collaboration with Brightbeam, where we’ll explore the transformative potential of Generative AI in the biopharmaceutical industry. When: 28th November 2024, 14:00 (Dublin time, GMT) What to Expect: An introduction to the fundamentals of Generative AI Real-world applications and lessons learnt A practical use case roadmap to help you integrate AI into your business effectively Open Q&A session Who Should Attend: Ideal for professionals in Learning & Organisation Development, Digital Transformation, IT, Manufacturing, QA, Regulatory Affairs, and leaders in biopharma interested in actionable insights on Generative AI. Register now https://hubs.la/Q02XSfW40

NIBRT is delighted to share a case study highlighting our collaboration with Meissner on customised training programmes for their Engineering and Sales teams in 2024. Key Outcomes: • Improved Customer Engagement: Both the Application Engineer and Sales teams have deepened their understanding of biopharma manufacturing, enabling them to further apply their technical knowledge when engaging with customers. • Specialised Insights: Broader industry knowledge for tailored solutions. This will improve the team’s ability to provide effective and meaningful solutions to customers. • Skill Development: Hands-on sessions aligning theory with real-world applications. This training was highly rated by both trainees and management: -Overall course quality 9.2/10 -Trainer rating 9.5/10 -NIBRT facility rating 9.2/10 Looking to customise training for your team in 2025? Contact us at training@nibrt.ie to secure your preferred dates. Read the full case study to learn more: https://hubs.la/Q02YXBS20 Kate Cotter Killian O'Driscoll John Milne PhD John O'Shea, MBA Jennifer Lawlor Lisa McNama Tom Kelly Claire Duffy

We're thrilled to highlight BioHub Maryland's global partner, NIBRT National Institute for Bioprocessing Research and Training! As the exclusive provider in the National Capital Region, we are proud to bring world-class biopharmaceutical training to our local workforce. A heartfelt thank you to the incredible NIBRT trainers, Shada W., Ciara Finn, and Tadeusz Tazbierski for joining us for the first MasterClass and to NIBRT CEO Darrin Morrissey for being part of our Ribbon Cutting Ceremony! Your expertise and partnership are paving the way for innovation and growth in Maryland’s biopharma sector.

Advancing Biomanufacturing in Africa: NIBRT Supports IPD’s First Vaccine Manufacturing Course   Last week, two of NIBRT’s training staff, John Milne PhD Milne and Dermot O Sullivan O’Sullivan, travelled to Dakar, Senegal, to contribute to the inaugural "Introduction to Vaccine Manufacturing" course.   This programme was organised by the Institut Pasteur de Dakar (IPD) in partnership with the Africa Centres for Disease Control and Prevention (Africa CDC) and supported by the MADIBA Workforce Development Programme, an IPD initiative with the Mastercard Foundation.   IPD is the latest member of NIBRT’s global partner programme, where we support organisations in developing advanced biopharma manufacturing capabilities by enabling them to licence NIBRT’s expertise to deliver biopharma training and education in their local region.   This programme represents an important step in Africa’s journey towards vaccine sovereignty, aligned with the Africa CDC’s target of producing 60% of the continent’s vaccines locally by 2040. It united participants from across the continent, all contributing to the development of a robust and self-reliant biomanufacturing ecosystem in Africa.   We extend our thanks to the incredible team at IPD, including Marieme Sy, Paul Xavier Etter, Fatou Kine Sambe, Farida Tairou, Amadou Sall and all the trainees for their warm welcome and engagement.   NIBRT was proud to participate in this high impact programme, which highlights the power of collaboration in advancing healthcare. John Milne PhD Killian O'Driscoll Dermot O Sullivan

Short Course: Annex I: A Practical Perspective - This January at NIBRT Join us for a one-day in-person course on 21 January 2025, designed to equip you with the latest updates and practical applications of Annex I for sterile medicinal drug product manufacturing in biopharma. Course Title: Annex I: A Practical Perspective When: 21 January 2025 Course Delivery: One Day Onsite at NIBRT Facility Enrol Here: https://hubs.la/Q02YytZ70 What to Expect: A high-level overview of Annex I in the context of the regulatory environment, highlighting key updates and hands-on experience in NIBRT’s state-of-the-art pilot plant, including our new fill-finish line, to gain a practical perspective. Key Topics: -Annex I – Updates and How they are applied  -PUPSIT – How to, the risks and challenges  -EM for Fill Finish – considerations and set-up  -Application of Annex I updates to drug product manufacture   Who Should Attend: This course is ideal for companies and individuals seeking to upskill their operations staff on Annex I updates and their implications for sterile drug product manufacturing. Enrol Here: https://hubs.la/Q02YytZ70

Just One Week to Go! Join us for a joint webinar in partnership with bioMérieux. We will focus on quality control (QC) microbiology in the different types of advanced therapy medicinal products (ATMP) manufacturing. This session will dive into essential topics, providing practical insights into phase-specific regulatory requirements, testing methodologies, and the latest in rapid microbiological methods. Title: ATMP Manufacturing - QC Micro Method Phase Selection Date & Time: Tuesday 26th November, 14:00-15:00 GMT / 15:00-16:00 CET Our Experts Will Discuss: -ATMP Manufacturing and QC Micro Testing Strategies -Regulatory Requirements for Phase Progression -Compendial versus Alternative Testing Methods -Manufacturing Processes and QC Requirements in Different ATMPs -Implementation and Phase Appropriate Validation of Rapid Microbiology Methods Register https://lnkd.in/euTy-e3i

NIBRT National Institute for Bioprocessing Research and Training welcomed groups of 5th and 6th year students from two local secondary schools this week for Science Week. The students heard talks from our researchers about cell therapy, viruses and STEM career paths before taking part in a contamination control practical with the NIBRT training team. They also had a facility tour visiting the research labs, CONCEPT and the pilot plant. A great opportunity for the scientists at NIBRT to inspire the biopharma scientists of the future! #ScienceWeek #FutureScientists #CommunityEngagement

80% HCI-Funded Level 6 & Level 9 Biopharma Courses Starting January – Apply Now! We are pleased to announce that ATU, in partnership with NIBRT, is offering four high-demand Level 6 and Level 9 courses with 80% HCI (Human Capital Initiative) funding. These programmes are designed to equip participants with essential skills and knowledge in biopharmaceutical processing and advanced therapeutic medicinal products (ATMPs). Starting this January, the courses will be delivered primarily online, with a brief practical component at the NIBRT facility. With limited places available, we encourage early applications to secure a place. This HCI funding provides a unique opportunity to upskill in the growing biopharma sector without high course fees. Level 9 Certificate in Biopharmaceutical Processing Apply: https://hubs.la/Q02YbngS0 Level 9 Certificate in ATMP Vector Manufacturing Apply: https://hubs.la/Q02Ybm8N0 Level 6 Certificate in Biopharmaceutical Processing Apply: https://hubs.la/Q02YbF2Z0 Level 6 Certificate in Aseptic Biopharmaceutical Operations Apply: https://hubs.la/Q02YbpnY0 LIMITED PLACES – BOOK NOW TO SECURE YOUR PLACE!

We were delighted to welcome Lee Markwick from eXmoor Pharma to NIBRT today to give a seminar entitled “Proper planning prevents CMC disasters for Cell & Gene Therapies”. Lee met with the research and training teams and visited the facility including a tour of CONCEPT with NIBRT’s Business Manager for Research William McCormack.

Join us for a joint webinar in partnership with bioMérieux. We will focus on quality control (QC) microbiology in the different types of advanced therapy medicinal products (ATMP) manufacturing. This session will dive into essential topics, providing practical insights into phase-specific regulatory requirements, testing methodologies, and the latest in rapid microbiological methods. Title: ATMP Manufacturing - QC Micro Method Phase Selection Date & Time: Tuesday 26th November, 14:00-15:00 GMT / 15:00-16:00 CET Our Experts Will Discuss: -ATMP Manufacturing and QC Micro Testing Strategies -Regulatory Requirements for Phase Progression -Compendial versus Alternative Testing Methods -Manufacturing Processes and QC Requirements in Different ATMPs -Implementation and Phase Appropriate Validation of Rapid Microbiology Methods Register https://lnkd.in/euTy-e3i Christie Downing-Kay Emily Boiocchi, MSci Dermot O Sullivan Hannah Rushe, PhD